Guangxin Jin
Papers
1
Total Citations
3
H-Index
1
About
Dr. Guangxin Jin is a leading authority in the diagnosis and treatment of pancreatic neuroendocrine neoplasms (pNENs), a rare and highly heterogeneous tumor type that accounts for roughly 3% of all pancreatic malignancies. His most impactful contribution is spearheading the Chinese Medical Association consensus for standardized diagnosis and treatment of pNENs (2023), a landmark guideline that harmonizes clinical approaches to these complex, pluripotent stem cell-derived tumors. This work is critical given the rising global incidence of pNENs and the challenges posed by their biological diversity. Dr. Jin’s research focuses on translating pathological insights into actionable clinical protocols, directly improving patient stratification and therapeutic outcomes. His consensus paper, already cited 3 times, serves as a foundational reference for clinicians and researchers navigating the nuances of pNEN management. Through this effort, Dr. Jin has established himself as a key figure in advancing standardized care for rare neuroendocrine cancers, bridging the gap between molecular understanding and real-world clinical practice. His work continues to shape how these challenging tumors are diagnosed and treated in China and beyond.
Research Focus
Key Achievements
Top Papers
- 1